PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE II GRANT

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

Recent Posts

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...

PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most...